A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.

Ivonescimab helped cut the risk of lung tumor progression in half in a multi-country Phase 3 trial. But it hasn’t yet clearly ...

Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...

Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

A therapy at the center of their $22 billion alliance failed to extend survival in a type of lung tumor, leading the ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

A grandad with advanced lung cancer, which often leaves patients dead within four months has become free of the disease after ...

The new "liquid biopsy" test searches for tiny fragments of DNA that are shed by tumours into the bloodstream - it can ...

“Lung cancer is a disease where uncontrolled cell growth occurs in the lung leading to tumours,” explains Dr Jenny Messenger, consultant in respiratory and general medicine at Nuffield Health Brighton ...

Announcing the rollout on the eve of the world’s largest cancer conference, which will take place in Chicago from Friday, NHS ...

Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...